Protein binding of drugs

Area of Science:

• Pharmacology
• Biochemistry
• Clinical Chemistry

Background:

• Drug-protein interactions are fundamental in pharmacokinetics and pharmacodynamics.
• The unbound fraction of a drug in plasma is the pharmacologically active component.
• Understanding these interactions is key to optimizing drug therapy and minimizing toxicity.

Purpose of the Study:

• To review the basic principles of drug-protein interactions.
• To emphasize the significance of unbound drug concentration in clinical outcomes.
• To recommend a suitable method for measuring unbound drug concentrations in plasma.

Main Methods:

• Literature review of drug-protein interaction principles.
• Discussion of the role of unbound drug concentration.
• Evaluation of analytical methods for determining unbound drug levels.

Main Results:

• Drug concentration at the site of action is directly related to the unbound drug concentration in plasma.
• Therapeutic and toxic effects are primarily governed by the unbound drug concentration.
• Ultrafiltration is identified as a reliable method for measuring unbound drug concentrations.

Conclusions:

• The concentration of unbound drug in plasma is a critical determinant of drug efficacy and toxicity.
• Accurate measurement of unbound drug concentrations is essential for personalized medicine.
• Ultrafiltration is the recommended method for clinical application due to its accuracy and practicality.